Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
$763M |
| 2 |
Amazon
AMZN
|
$688M |
| 3 |
TSMC
TSM
|
$562M |
| 4 |
Tesla
TSLA
|
$419M |
| 5 |
Johnson & Johnson
JNJ
|
$398M |
Top Sells
| 1 |
Microsoft
MSFT
|
$891M |
| 2 |
Home Depot
HD
|
$441M |
| 3 |
Novo Nordisk
NVO
|
$366M |
| 4 |
JPMorgan Chase
JPM
|
$335M |
| 5 |
ASML
ASML
|
$325M |
Sector Composition
| 1 | Healthcare | 20.8% |
| 2 | Technology | 15.52% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Consumer Staples | 10.11% |
| 5 | Financials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Novartis
NVS
$248B
| $310M | 0.42% |
3,420,970
+239,100
| +8% | +$21.7M |
|
27
Monster Beverage
MNST
$61.6B
| $305M | 0.42% |
3,005,417
-1,058,043
| -26% | -$107M |
|
28
Abbott
ABT
$227B
| $304M | 0.42% |
2,764,566
+240,308
| +10% | +$26.4M |
|
29
Coca-Cola
KO
$292B
| $292M | 0.4% |
4,592,591
-2,241,843
| -33% | -$143M |
|
30
Roblox
RBLX
$92.4B
| $289M | 0.4% |
10,150,982
-470,700
| -4% | -$13.4M |
|
31
McDonald's
MCD
$226B
| $288M | 0.39% |
1,094,544
+605,144
| +124% | +$159M |
|
32
Humana
HUM
$37.3B
| $286M | 0.39% |
558,600
+125,000
| +29% | +$64M |
|
33
UnitedHealth
UNH
$277B
| $286M | 0.39% |
+538,677
| New | +$286M |
|
34
Eli Lilly
LLY
$658B
| $283M | 0.39% |
773,354
-241,293
| -24% | -$88.3M |
|
35
Wells Fargo
WFC
$257B
| $281M | 0.38% |
6,813,816
+6,737,405
| +8,817% | +$278M |
|
36
Biogen
BIIB
$20.8B
| $277M | 0.38% |
1,000,276
-154,231
| -13% | -$42.7M |
|
37
Palantir
PLTR
$371B
| $276M | 0.38% |
43,000,160
+9,870,113
| +30% | +$63.4M |
|
38
Cheniere Energy
LNG
$52.8B
| $275M | 0.38% |
1,836,348
+959,800
| +109% | +$144M |
|
39
Pinduoduo
PDD
$176B
| $274M | 0.37% |
3,360,100
+2,039,200
| +154% | +$166M |
|
40
US Bancorp
USB
$75.2B
| $274M | 0.37% |
6,281,500
+1,018,900
| +19% | +$44.4M |
|
41
Colgate-Palmolive
CL
$67.3B
| $269M | 0.37% |
3,410,891
-698,495
| -17% | -$55M |
|
42
CME Group
CME
$96.7B
| $268M | 0.37% |
1,595,089
+1,078,500
| +209% | +$181M |
|
43
Snowflake
SNOW
$76.8B
| $266M | 0.36% |
1,851,899
+690,200
| +59% | +$99.1M |
|
44
General Mills
GIS
$26.4B
| $255M | 0.35% |
3,040,188
-639,700
| -17% | -$53.6M |
|
45
Cboe Global Markets
CBOE
$24.5B
| $254M | 0.35% |
2,027,124
-124,400
| -6% | -$15.6M |
|
46
Citigroup
C
$173B
| $253M | 0.35% |
5,603,820
+1,157,700
| +26% | +$52.4M |
|
47
Atlassian
TEAM
$44.9B
| $251M | 0.34% |
1,953,323
-258,297
| -12% | -$33.2M |
|
48
AstraZeneca
AZN
$254B
| $245M | 0.34% |
3,617,846
-2,181,726
| -38% | -$148M |
|
49
Exelixis
EXEL
$9.97B
| $240M | 0.33% |
14,961,089
-1,069,755
| -7% | -$17.2M |
|
50
Meta Platforms (Facebook)
META
$1.85T
| $239M | 0.33% |
1,987,280
+1,142,280
| +135% | +$137M |
|